Icon
+91 94997 68112
Login Register

Sprix - (15.75 mg/SPRAY (NASAL))

Ketorolac Tromethamine LUITPOLD
15.75 mg/SPRAY (NASAL)
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
SPRIX is indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
Yes
****** ** ****** ** ** *** *** **** **** ** **** ****** '***-*** **, ****. *** ************ ********* ** ******** ** ******** ***** ** *** ******. ***** ****** **** ***** **** ** **** **** ****** *** *** ************ *********. ********** ** ********* **** **** ****** *** ****** ***** *** ***** ** ********* *** *** ***** *** ** ****** *** ******** ** ***** ******** ****** *** ****.
Sprix Patent 1
****** *******
****** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** **, **** ******* **** ****** **** ********
****** ** \ ** *** **, **** ******* **** ****** **** ********
  1. **** **, **** : ****** ******** ******** ***** *** **** ** *********** ****** '***-*** **, ****.
  2. *** **, **** : ******** **** ****** ** ******** ***** ** *** ******.
  3. *** **, **** : ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****.
  4. *** **, **** : ******** ***** * **** ******* ****** ** ****** ***** **** ** **** ****** '***-*** **, ****.
  5. *** *, **** : ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.